Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Non-cash Items (2018 - 2020)

Neurogene's Non-cash Items history spans 3 years, with the latest figure at $42.1 million for Q3 2020.

  • For Q3 2020, Non-cash Items changed N/A year-over-year to $42.1 million; the TTM value through Sep 2020 reached $42.1 million, changed N/A, while the annual FY2019 figure was $45.0 million, 3646.63% up from the prior year.
  • Non-cash Items reached $42.1 million in Q3 2020 per NGNE's latest filing, down from $67.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $67.0 million in Q2 2020 to a low of $1.0 million in Q1 2020.
  • Average Non-cash Items over 3 years is $17.9 million, with a median of $1.2 million recorded in 2018.
  • Peak YoY movement for Non-cash Items: soared 3646.63% in 2019, then dropped 3.77% in 2020.
  • A 3-year view of Non-cash Items shows it stood at $1.2 million in 2018, then skyrocketed by 3646.63% to $45.0 million in 2019, then fell by 6.43% to $42.1 million in 2020.
  • Per Business Quant, the three most recent readings for NGNE's Non-cash Items are $42.1 million (Q3 2020), $67.0 million (Q2 2020), and $1.0 million (Q1 2020).